Korea Ginseng Corp. uncovers more evidence red ginseng could help stop Alzheimer’s

Korea Ginseng Corp. said that a collaborative research team that it co-supports with Konyang University has found a potential mechanism in red ginseng polysaccharides that reduces cognitive decline in Alzheimer's disease.

The mechanism that red ginseng polysaccharides are related to synaptic and mitochondrial pathways in Alzheimer's disease was identified in this year’s research.

With an analysis of the protein-protein interaction of 111 proteins significantly changed by injecting red ginseng polysaccharide in mice, the research team found that the protein interaction decreased significantly.

Bioinformatics analysis confirmed that these proteins play an important role in nerve and synaptic development and function related to Alzheimer's disease, contributing to the preservation of mitochondrial forms.

How red ginseng polysaccharides do this was not fully clarified due to a lack of research two years ago.

"This study is meaningful because it has confirmed the possibility of red ginseng polysaccharides as candidates for effective treatments of Alzheimer's disease in animal models,” said Moon Min-ho, a professor at the College of Medicine at Konyang University.

In 2021, Konyang University’s Research Institute for Dementia Science, led by Professor Moon Min-ho, and Korea Ginseng Corporation's Research Institute team, led by Lee Yong-yook, announced in the international scientific journal Free Radical Biology and Medicine that red ginseng polysaccharide inhibits amyloid beta aggregation.

Alzheimer's occurs when amyloid beta, a proposed cause of Alzheimer's, aggregates and accumulates in the brain.